ASH HIGHLIGHTS 2023 – LYMPHOMA ROUNDTABLE DISCUSSION: Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine for Early-Stage and Advanced Classical Hodgkin Lymphoma | Best of Oncology Podcast Series | lystn.fm

ASH HIGHLIGHTS 2023 – LYMPHOMA ROUNDTABLE DISCUSSION: Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine for Early-Stage and Advanced Classical Hodgkin Lymphoma

2356 232

ASH HIGHLIGHTS 2023 – LYMPHOMA ROUNDTABLE DISCUSSION: Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine for Early-Stage and Advanced Classical Hodgkin Lymphoma2 years ago

06:36

Suggested Podcasts

Clinical Research Podcast

I’ve Got a Beatles Podcast!

The Self-ish Latina Podcast

The Backyard Buddhist Podcast

Shojo & Tell: A Manga Podcast

Undercovers

We Are Film Podcast

Living in the moment

Hit & Miss

Tree of Life

Download the app

Get it on Google Play Available on the App Store

PRIVACY POLICY | TERMS AND CONDITIONS

lystn.fm © 2025.
ALL RIGHTS RESERVED. CONTENT IS COPYRIGHT OF RESPECTIVE CONTENT OWNERS.